# Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection

> **NCT02414880** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Cirrhosis and Chronic Liver Disease

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine
- **DRUG:** Rocuronium

## Key facts

- **NCT ID:** NCT02414880
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02414880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02414880, "Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02414880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*